|
Sign In to gain access to subscriptions and/or personal tools.
|
Induction of Lung Lesions in Female Rats Following Chronic Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin
Angelika M. Tritscher
Nestle Research Center, PO Box 44, CH-1000 Lausanne 26, Switzerland, tritscher{at}rdls.nestle.com
Joel Mahler
Laboratory of Experimental Pathology
Christopher J. Portier
Laboratory of Computational Biology and Risk Analysis, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA
George W. Lucier
Laboratory of Computational Biology and Risk Analysis, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA
Nigel J. Walker
Laboratory of Computational Biology and Risk Analysis, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA
2,3,7,8,-Tetrachlorodibenzo- p-dioxin (TCDD) has been classified as a known human carcinogen, and epidemiologic studies identify the lung as one of the target organs. Few experimental studies have attempted to characterize pulmonary effects of TCDD exposure. In this study, we characterize the induction of lesions in the lung by chronic oral TCDD exposure in diethylnitrosamine (DEN)-initiated or noninitiated female Sprague-Dawley rats. Two or 18 weeks after initiation, rats were treated with TCDD continuously for 14, 30, or 60 weeks by biweekly oral gavage (1,750 ng TCDD/kg) at a dose equivalent to 125 ng/kg body weight per day (controls received corn oil). To assess the time dependence and reversibility of potential changes, some groups included withdrawal periods of 16 or 30 weeks after 30 weeks of TCDD treatment. TCDD treatment alone for 60 weeks caused significant increases in alveolar-bronchiolar (AB) metaplasia. TCDD treatment of DEN-initiated animals for 60 weeks resulted in a significant increase in bronchiolar epithelial hyperplasia. These increases were not observed in animals treated with TCDD for 30 weeks followed by corn oil for 30 weeks, indicating that the development of these lesions required continuous exposure to TCDD. AB hyperplasia increased in an age-dependent manner after DEN initiation but was unaffected by TCDD treatment. Expression of the aromatic hydrocarbon receptor (AHR) and induction of CYP1A1 was observed only in bronchiolar Clara and ciliated cells, indicating that the mechanism of induction of AB metaplasia may be mediated by the AHR. TCDD elimination half-life was monophasic in the lung, and serum and was estimated to be 39.7 days and 44.6 days, respectively, independent of age, tissue TCDD concentration, or body weight. This is the first report to identify the AB region as a target for TCDD-induced metaplastic and proliferative changes after chronic oral exposure.
Key Words: TCDD hyperplasia metaplasia tissue concentration CYP1A1 half-life
References
- Anderson LM, Beebe LE, Fox SD, Issaq HJ, Kovatch RM (1991). Promotion of mouse lung tumors by bioaccumulated polychlorinated aromatic hydrocarbons. Exp Lung Res 17: 455-471.[Web of Science][Medline]
[Order article via Infotrieve]
- Beebe LE, Anver MR, Riggs CW, Fomwald LW, Anderson LM (1995). Promotion of N-nitrosodimethylamine-initiated mouse lung tumors following single or multiple low dose exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Carcinogenesis 16: 1345-1349.[Abstract/Free Full Text]
- Beebe LE, Fomwald LW, Diwan BA, Anver MR, Anderson LM (1995). Promotion of N-nitrosodiethylamine-initiated hepatocellular tumors and hepatoblastomas by 2,3,7,8-tetrachlorodibenzo-p-dioxin or Aroclor 1254 in C57BL/6, DBA/2, and B6D2F1 mice. Cancer Res 55: 4875-4880.[Abstract/Free Full Text]
- Bertazzi PA, Pesatori AC, Consonni D., Tironi A., Landi MT, Zochetti C. (1993). Cancer incidence in a population accidentally exposed to 2,3,7,8-tetrachlorodibenzo-para-dioxin. Epidemiology 4: 398-406.[Web of Science][Medline]
[Order article via Infotrieve]
- Bertazzi PA, Zocchetti C., Guercilena S., Consonni D., Tironi A., Landi MT, Pesatori AC (1997). Dioxin exposure and cancer risk: A 15-year mortality study after the "Seveso accident." Epidemiology 8: 646-652.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Clark G., Tritscher A., Maronpot R., Foley J., Lucier G. (1991). Tumor promotion by TCDD in female rats. In: Banbury Report 35: Biological Basis for Risk Assessment of Dioxins and Related Compounds. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, pp 389-404.
- Columbano A., Rajalakshmi S., Sarma DS (1981). Requirement of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures. Cancer Res 41: 2079-2083.[Abstract/Free Full Text]
- Columbano A., Shinozuka H. (1996). Liver regeneration versus direct hyperplasia. FASEB J 10: 1118-1128.[Abstract]
- Davis BJ, McCurdy EA, Miller BD, Lucier GW, Tritscher AM (2000). Ovarian cancer in rats induced by chronic 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment. Cancer Res (in press).
- Fingerhut MA, Halperin WE, Marlow DA, Piacitelli LA, Honchar PA, Sweeney MH, Greife AL, Dill PA, Saruda KS, Suruda AJ (1991). Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. N Engl J Med 324: 212-218.[Abstract]
- Gaido KW, Maness SC (1994). Regulation of gene expression and acceleration of differentiation in human keratinocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 127: 199-208.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Grassman JA, Masten SA, Walker NJ, Lucier GW (1998). Animal models of human response to dioxins. Environ Health Perspect 106(suppl 2): 761-775.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Greenlee WF, Dold KM, Osborne R. (1985). Actions of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human epidermal keratinocytes in culture. In Vitro Cell Dev Biol 21: 509-512.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hayashi S., Watanabe J., Nakachi K., Eguchi H., Gotoh O., Kawajiri K. (1994). Interindividual difference in expression of human Ah receptor and related P450 genes. Carcinogenesis 15: 801-806.[Abstract/Free Full Text]
- Herbert RA, Gillett NA, Rebar AH, Lundgren DL, Hoover MD, Chang IY, Carlton WW, Hahn FF ( 1993). Sequential analysis of the pathogenesis of plutonium-induced pulmonary neoplasms in the rat: Morphology, morphometry, and cytokinetics. Radiat Res 134: 29-42.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Huff J., Lucier G., Tritscher A. (1994). Carcinogenicity of TCDD: Experimental, mechanistic, and epidemiologic evidence. Annu Rev Pharmacol Toxicol 34: 343-372.[Web of Science][Medline]
[Order article via Infotrieve]
- International Agency for Research on Cancer (1997). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 69. Polychlorinated Dibenzo-para-dioxins and Polychlorinated Dibenzofurans. IARC, Lyon, France.
- Kennedy AR, McGandy RB, Little JB (1977). Histochemical, light and electron microscopic study of polonium-210 induced peripheral tumors in hamster lungs: Evidence implicating the Clara cell as the cell of origin. Eur J Cancer 13: 1325-1340.[Medline]
[Order article via Infotrieve]
- Kociba RJ, Keyes DG, Beyer JE, Carreon RM, Wade CE, Dittenber DA, Kalnins RP, Frauson LE, Park CN, Barnard SD, Hummel RA, Humiston CG (1978). Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol 46: 279-303.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kogevinas M., Becher H., Benn T., et al (1997). Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins: An expanded and updated international cohort study. Am J Epidemiol 145: 1061-1075.[Abstract/Free Full Text]
- Lucier GW, Tritscher A., Goldsworthy T., Foley J., Clark G., Goldstein J., Maronpot R. (1991). Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis. Cancer Res 51: 1391-1397.[Abstract/Free Full Text]
- McMartin DN, Sahota PS, Gunson DE, Hsu HH, Spaet RH (1992). Neoplasms and related proliferative lesions in control Sprague-Dawley rats from carcinogenicity studies: Historical data and diagnostic considerations. Toxicol Pathol 20: 212-225.[Web of Science][Medline]
[Order article via Infotrieve]
- Nagai H. (1994). Goblet cell metaplasia in the pulmonary alveolar epithelium in a rat. Toxicol Pathol 22: 555-558.[Abstract/Free Full Text]
- National Toxicology Program ( 1982). Bioassay of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin for Possible Carcinogenicity (Gavage Study). Technical Report Series No 209, National Toxicology Program, Research Triangle Park, North Carolina.
- Nessel CS, Amoruso MA, Umbreit TH, Meeker RJ, Gallo MA (1992). Pulmonary bioavailability and fine particle enrichment of 2,3,7,8-tetrachlorodibenzo-p-dioxin in respirable soil particles. Fundam Appl Toxicol 19: 279-285.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Nettesheim P., Szakal AK (1972). Morphogenesis of alveolar bronchiolization. Lab Invest 26: 210-219.[Web of Science][Medline]
[Order article via Infotrieve]
- Omiecinski CJ, Redlich CA, Costa P. (1990). Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues: Detection by the polymerase chain reaction. Cancer Res 50: 4315-4321.[Abstract/Free Full Text]
- Patterson DG, Jr., Needham LL, Pirkle JL, Roberts DW, Bagby J., Garrett WA, Andrews JS Jr, Falk H., Bemert JT, Sampson EJ, Houk VN (1988). Correlation between serum and adipose tissue levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin in 50 persons from Missouri. Arch Environ Contam Toxicol 17: 139-143.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Poland A., Knutson JC (1982). 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: Examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 22: 517-554.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Rehm S., Kelloff GJ (1991). Histologic characterization of mouse bronchiolar cell hyperplasia, metaplasia, and neoplasia induced intratracheally by 3- methylcholanthrene. Exp Lung Res 17: 229-244.[Web of Science][Medline]
[Order article via Infotrieve]
- Roberts EA, Golas CL, Okey AB ( 1986). Ah receptor mediating induction of aryl hydrocarbon hydroxylase: detection in human lung by binding of 2,3,7,8-[3H]tetrachlorodibenzo-p-dioxin. Cancer Res 46: 3739-3743.[Abstract/Free Full Text]
- Santostefano MJ, Johnson KL, Whisnant NA, Richardson VM, DeVito MJ, Diliberto JJ, Birnbaum LS (1996). Subcellular localization of TCDD differs between the liver, lungs, and kidneys after acute and subchronic exposure: Species/dose comparisons and possible mechanism. Fundam Appl Toxicol 34: 265-275.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Santostefano MJ, Wang X., Richardson VM, Ross DG, DeVito MJ, Birnbaum LS (1998). A pharmacodynamic analysis of TCDD-induced cytochrome P450 gene expression in multiple tissues: Dose-and time-dependent effects. Toxicol Appl Pharmacol 151: 294-310.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Schmidt JV, Bradfield CA (1996). Ah receptor signaling pathways. Annu Rev Cell Dev Biol 12: 55-89.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Steenland K., Piacitelli L., Deddens J., Fingerhut M., Chang LI (1999). Cancer, heart disease, and diabetes in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Natl Cancer Inst 91: 779-786.[Abstract/Free Full Text]
- Tritscher AM, Goldstein JA, Portier CJ, McCoy Z., Clark GC, Lucier GW (1992). Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: Quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver. Cancer Res 52: 3436-3442.[Abstract/Free Full Text]
- Walker NJ, Miller BD, Kohn MC, Lucier GW, Tritscher AM (1998). Differences in kinetics of induction and reversibility of TCDD-induced changes in cell proliferation and CYP1A1 expression in female Sprague-Dawley rat liver. Carcinogenesis 19: 1427-1435.[Abstract/Free Full Text]
- Walker NJ, Tritscher AM, Sills RC, Lucier GW, Portier CJ (2000). Hepatocarcinogenesis in female Sprague-Dawley rats following discontinuous treatment with 2,3,7,8 tetrachlorodibenzo-p-dioxin. Toxicol Sci 54: 330-337.[Abstract/Free Full Text]
- Whitlock J. P Jr. (1990). Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Annu Rev Pharmacol Toxicol 30: 251-277.[Web of Science][Medline]
[Order article via Infotrieve]
- Yoshida Y., Tatematsu M., Takaba K., Iwasaki S., Ito N. ( 1993). Target organ specificity of cell proliferation induced by various carcinogens. Toxicol Pathol 21: 436-442.[Abstract/Free Full Text]
Toxicologic Pathology, Vol. 28, No. 6,
761-769 (2000)
DOI: 10.1177/019262330002800601

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. J. Walker, K. Yoshizawa, R. A. Miller, A. E. Brix, D. M. Sells, M. P. Jokinen, M. E. Wyde, M. Easterling, and A. Nyska
Pulmonary Lesions in Female Harlan Sprague-Dawley Rats Following Two-Year Oral Treatment with Dioxin-Like Compounds
Toxicol Pathol,
December 1, 2007;
35(7):
880 - 889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Vorderstrasse and B. P. Lawrence
Protection against Lethal Challenge with Streptococcus pneumoniae Is Conferred by Aryl Hydrocarbon Receptor Activation but Is Not Associated with an Enhanced Inflammatory Response.
Infect. Immun.,
October 1, 2006;
74(10):
5679 - 5686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Chang, L. W. Chang, Y.-H. Cheng, W.-T. Tsai, M.-X. Tsai, and P. Lin
Preferential Induction of CYP1A1 and CYP1B1 in CCSP-Positive Cells
Toxicol. Sci.,
January 1, 2006;
89(1):
205 - 213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Teske, A. A. Bohn, J. F. Regal, J. J. Neumiller, and B. P. Lawrence
Activation of the aryl hydrocarbon receptor increases pulmonary neutrophilia and diminishes host resistance to influenza A virus
Am J Physiol Lung Cell Mol Physiol,
July 1, 2005;
289(1):
L111 - L124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nyska, K. Yoshizawa, M. P. Jokinen, A. E. Brix, D. M. Sells, M. E. Wyde, D. P. Orzech, G. E. Kissling, and N. J. Walker
Olfactory Epithelial Metaplasia and Hyperplasia in Female Harlan Sprague-Dawley Rats Following Chronic Treatment with Polychlorinated Biphenyls
Toxicol Pathol,
April 1, 2005;
33(3):
371 - 377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Brix, M. P. Jokinen, N. J. Walker, D. M. Sells, and A. Nyska
Characterization of Bronchiolar Metaplasia of the Alveolar Epithelium in Female Sprague--Dawley Rats Exposed to 3,3',4,4',5-Pentachlorobiphenyl (PCB126)
Toxicol Pathol,
April 1, 2004;
32(3):
333 - 337.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Pinpin Lin, Han Chang, W.-T. Tsai, M.-H. Wu, Y.-S. Liao, J.-T. Chen, and J.-M. Su
Overexpression of Aryl Hydrocarbon Receptor in Human Lung Carcinomas
Toxicol Pathol,
January 1, 2003;
31(1):
22 - 30.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Martinez, C. A. Afshari, P. R. Bushel, A. Masuda, T. Takahashi, and N. J. Walker
Differential Toxicogenomic Responses to 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Malignant and Nonmalignant Human Airway Epithelial Cells
Toxicol. Sci.,
October 1, 2002;
69(2):
409 - 423.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|